Peng Wen-xing

1.1k total citations
53 papers, 847 citations indexed

About

Peng Wen-xing is a scholar working on Pharmacology, Nephrology and Pharmacology. According to data from OpenAlex, Peng Wen-xing has authored 53 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 8 papers in Nephrology and 8 papers in Pharmacology. Recurrent topics in Peng Wen-xing's work include Drug-Induced Hepatotoxicity and Protection (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Peng Wen-xing is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Peng Wen-xing collaborates with scholars based in China, Sweden and Australia. Peng Wen-xing's co-authors include Xueqing Yu, Qizhi Zhang, LI Huan-de, Xuan Cheng, Jinjin Fan, Yun Li, Ronghua Zhu, Jing Nie, Hong‐Hao Zhou and Bikui Zhang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Peng Wen-xing

52 papers receiving 824 citations

Peers

Countries citing papers authored by Peng Wen-xing

Since Specialization

Citations

This map shows the geographic impact of Peng Wen-xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Wen-xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Wen-xing more than expected).

Fields of papers citing papers by Peng Wen-xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Wen-xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Wen-xing. The network helps show where Peng Wen-xing may publish in the future.

Co-authorship network of co-authors of Peng Wen-xing

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Wen-xing. A scholar is included among the top collaborators of Peng Wen-xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Wen-xing. Peng Wen-xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis 2025 ·BMC Medicine ·Liwei Huang, Huamin Li, Bei He, Xiaobo Wang, Qizhi Zhang, Peng Wen-xing	7
2	Glomerular Exostosin-Positivity is Associated With Disease Activity and Outcomes in Patients With Membranous Lupus Nephritis 2024 ·Kidney International Reports ·Xi Xia, (unknown), Zhipeng Wang, (unknown), Yuting Fan, Peng Wen-xing, Wenfang Chen, Fengxian Huang, Ruihan Tang, Wei Chen	3
3	Nirmatrelvir plus ritonavir remains effective in vaccinated patients at risk of progression with COVID-19: A systematic review and meta-analysis 2023 ·Journal of Global Health ·Huamin Li, (unknown), Bei He, Qizhi Zhang, Peng Wen-xing	7
4	Serum levels of IL-6/IL-10/GLDH may be early recognition markers of anti-tuberculosis drugs (ATB) -induced liver injury 2023 ·Toxicology and Applied Pharmacology ·(unknown), Yun Li, Xuan Cheng, (unknown), Huamin Li, Qizhi Zhang, Bin Wang, Peng Wen-xing	4
5	Longitudinal Relationship between Mobility Device Use, Falls and Fear of Falling (FOF) Differed by Frailty Status among Community-Dwelling Older Adults 2023 ·The journal of nutrition health & aging ·Minhui Liu, Cuiju Mo, Yang Luo, Peng Wen-xing, Siyuan Tang	2
6	Simultaneous surgical treatment of aortic coarctation and aortic root disease: a report of case series 2023 ·Journal of Thoracic Disease ·Bo Yang, Xiao‐Chun Duan, Huanyu Qiao, Yongmin Liu, Xiaona Wang, Peng Wen-xing	1
7	The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis 2022 ·Frontiers in Immunology ·Bei He, Yun Li, (unknown), Xuan Cheng, (unknown), Qizhi Zhang, (unknown), Peng Wen-xing	18
8	Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis 2021 ·Urologia Internationalis ·Yun Li, Xuan Cheng, (unknown), (unknown), (unknown), Qizhi Zhang, Peng Wen-xing	5
9	Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies 2020 ·Psychiatry Research ·(unknown), (unknown), Xuan Cheng, Yun Li, Qizhi Zhang, Peng Wen-xing	34
10	Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers 2018 ·Clinical Therapeutics ·(unknown), Yi Gong, Xiang‐Yu Hou, Yifan Zhang, Peng Wen-xing, Ronghua Zhu, Dafang Zhong, Xiaoyan Chen	6
11	Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model 2014 ·APOPTOSIS ·(unknown), Shunmin Li, Juan Wu, Wenfang Chen, Huili Sun, Peng Wen-xing, Xueqing Yu, Xiao Yang	33
12	Quantitative analysis of erythromycylamine in human plasma by liquid chromatography-tandem mass spectrometry and its application in a bioequivalence study of dirithromycin enteric-coated tablets with a special focus on the fragmentation pattern and carryover effect 2014 ·Journal of Chromatography B ·Hualin Cai, Feng Wang, LI Huan-de, Peng Wen-xing, Ronghua Zhu, Yang Deng, Pei Jiang, Miao Yan, (unknown), (unknown), Chang Chen	11
13	Validated HILIC–MS/MS assay for determination of vindesine in human plasma: Application to a population pharmacokinetic study 2014 ·Journal of Pharmaceutical and Biomedical Analysis ·Ronghua Zhu, LI Huan-de, Hualin Cai, Zhiping Jiang, Ping Xu, (unknown), Peng Wen-xing	13
14	Development and validation of a sensitive U-HPLC–MS/MS method with electrospray ionization for quantitation of ranolazine in human plasma: Application to a clinical pharmacokinetic study 2012 ·Journal of Chromatography B ·(unknown), Ronghua Zhu, LI Huan-de, Pingfei Fang, Miao Yan, Qizhi Zhang, Peng Wen-xing	3
15	Nonlinear pharmacokinetic properties of mildronate capsules: a randomized, open‐label, single‐ and multiple‐dose study in healthy volunteers 2011 ·Fundamental and Clinical Pharmacology ·Jun Zhang, (unknown), (unknown), Qizhi Zhang, Peng Wen-xing	11
16	Ultra-performance liquid chromatography–tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Ronghua Zhu, (unknown), Gang Cheng, Peng Wen-xing	32
17	Effects of tetramethylpyrazine on the function and expression of p-glycoprotein in Caco-2 cells 2007 ·Central South Pharmacy ·Peng Wen-xing	2
18	Smad7 gene transfer inhibits peritoneal fibrosis 2007 ·Kidney International ·Jing Nie, (unknown), Wenke Hao, Xin Wang, Peng Wen-xing, Zhanjun Jia, Wei Chen, (unknown), Ning Luo, Hui Y. Lan, Xueqing Yu	64
19	Determination of talinolol in human plasma by high performance liquid chromatography–electrospray ionization mass spectrometry: Application to pharmacokinetic study 2007 ·Journal of Chromatography B ·(unknown), B Terhaag, (unknown), Bikui Zhang, (unknown), (unknown), Juan Song, (unknown), Xiaolei Liu, Peng Wen-xing	5
20	Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers 2003 ·European Journal of Clinical Pharmacology ·Peng Wen-xing, LI Huan-de, Hong‐Hao Zhou	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact